Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction

Journal of Neuroscience Methods

Volumn 146, Issue 1, 2005, Pages 106-115

  Maeda, Masashi ^a   Takamatsu, Hiroyuki ^b   Furuichi, Yasuhisa ^a   Noda, Akihiko ^b   Awaga, Yuji ^b   Tatsumi, Mitsuyoshi ^b   Yamamoto, Masashi ^a   Ichise, Rikiya ^b   Nishimura, Shintaro ^b   Matsuoka, Nobuya ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b Medical and Pharmacological Research Center Foundation   (Japan)

Author keywords

Cerebral blood flow; Cyclic flow reduction; Focal cerebral ischemia; Non human primate; PET

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN MICROCIRCULATION; BRAIN PERFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; MALE; MICROTHROMBUS; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PHOTOSTIMULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOSIS; VASCULAR RESISTANCE;

ANIMALS; BIOLOGICAL MARKERS; CEREBRAL CORTEX; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBRINOGEN; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL THROMBOSIS; MACACA FASCICULARIS; MALE; MIDDLE CEREBRAL ARTERY; PEROXIDASE; PHOTIC STIMULATION; POSITRON-EMISSION TOMOGRAPHY; ROSE BENGAL; SURGICAL INSTRUMENTS;

EID: 20144374304     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2005.01.019     Document Type: Article

References (60)

1. A.V. Alexandrov, C.F. Bladin, and J.W. Norris Intracranial blood flow velocities in acute ischemic stroke Stroke 25 1994 1378 1383
2. A.V. Alexandrov, and J.C. Grotta Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator Neurology 59 2002 862 867
3. A. Ames III, R.L. Wright, M. Kowada, J.M. Thurston, and G. Majno Cerebral ischemia II. The no-reflow phenomenon Am J Pathol 52 1968 437 453
4. Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev, 2002, CD003242.
5. E. Braunwald, and R.A. Kloner Myocardial reperfusion: a double-edged sword? J Clin Invest 76 1985 1713 1719
6. M. Cerisoli, F. Ruggeri, G.F. Amelio, G. Giuliani, B. Bernardi, and M. Giulioni Experimental cerebral "no-reflow phenomenon" J Neurosurg Sci 25 1981 7 12
7. R.M. Crowell, F.W. Marcoux, and U. DeGirolami Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys Neurology 31 1981 1295 1302
8. G.J. del Zoppo, B.R. Copeland, T.A. Waltz, J. Zyroff, E.F. Plow, and L.A. Harker The beneficial effect of intracarotid urokinase on acute stroke in a baboon model Stroke 17 1986 638 643
9. G.J. del Zoppo, and J.M. Hallenbeck Advances in the vascular pathophysiology of ischemic stroke Thromb Res 98 2000 73 81
10. G.J. del Zoppo, R.T. Higashida, A.J. Furlan, M.S. Pessin, H.A. Rowley, and M. Gent PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism Stroke 29 1998 4 11
11. G.J. del Zoppo, G.W. Schmid-Schonbein, E. Mori, B.R. Copeland, and C.M. Chang Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons Stroke 22 1991 1276 1283
12. Dietrich WD, Watson BD, Busto R, Ginsberg MD, Bethea JR. Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol (Berl) 1987;315-25.
13. M. Fisher, P.H. Levine, A.L. Fullerton, A. Forsberg, C.P. Duffy, J.J. Hoogasian, and D.A. Drachman Marker proteins of platelet activation in patients with cerebrovascular disease Arch Neurol 39 1982 692 695
14. A. Furlan, R. Higashida, L. Wechsler, M. Gent, H. Rowley, C. Kase, M. Pessin, A. Ahuja, F. Callahan, W.M. Clark, F. Silver, and F. Rivera Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism JAMA 282 1999 2003 2011
15. Y. Furuichi, M. Maeda, A. Moriguchi, T. Sawamoto, A. Kawamura, N. Matsuoka, S. Mutoh, and T. Yanagihara Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in non-human primates J Cereb Blood Flow Metab 23 2003 1183 1194
16. L.A. Gillilan The arterial and venous blood supplies to the forebrain (including the internal capsule) of primates Neurology 18 1968 653 670
17. P.B. Gorelick, G.V. Born, R.B. D'Agostino, D.F. Hanley Jr., L. Moye, and C.J. Pepine Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel Stroke 30 1999 1716 1721
18. N. Heye, C. Paetzold, and J. Cervos-Navarro The role of microthrombi and microcirculatory factors in localization and evolution of focal cerebral ischemia Neurosurg Rev 14 1991 7 16
19. W.R. Hudgins, and J.H. Garcia Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies Stroke 1 1970 107 111
20. U. Ito, K. Ohno, T. Yamaguchi, H. Tomita, Y. Inaba, and M. Kashima Transient appearance of "no-reflow" phenomenon in Mongolian gerbils Stroke 11 1980 517 521
21. T.H. Jones, R.B. Morawetz, R.M. Crowell, F.W. Marcoux, S.J. FitzGibbon, U. DeGirolami, and R.G. Ojemann Thresholds of focal cerebral ischemia in awake monkeys J Neurosurg 54 1981 773 782
22. R. Joseph, G. D'Andrea, S.B. Oster, and K.M. Welch Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of anti-thrombotic agents Stroke 20 1989 38 44
23. S. Kaku, K. Umemura, A. Mizuno, S. Yano, K. Suzuki, T. Kawasaki, and M. Nakashima Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis Eur J Pharmacol 345 1998 185 192
24. K. Kawano, Y. Ikeda, K. Kondo, and K. Umemura Increased cerebral infarction by cyclic flow reductions: studies in the guinea pig MCA thrombosis model Am J Physiol 275 1998 1578 1583
25. G. Kito, A. Nishimura, T. Susumu, R. Nagata, Y. Kuge, C. Yokota, and K. Minematsu Experimental thromboembolic stroke in cynomolgus monkey J Neurosci Meth 105 2001 45 53
26. P.M. Kochanek, and J.M. Hallenbeck Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke Stroke 23 1992 1367 1379
27. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniectomy in rats Stroke 20 1989 84 91
28. M. Maeda, Y. Furuichi, N. Ueyama, A. Moriguchi, N. Satoh, N. Matsuoka, T. Goto, and T. Yanagihara A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window J Cereb Blood Flow Metab 22 2002 1205 1211
29. G. Marchal, A.R. Young, and J.C. Baron Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography J Cereb Blood Flow Metab 19 1999 467 482
30. T. Matsui, T. Nagafuji, T. Mori, and T. Asano N-omega-nitro-l-arginine attenuates early ischemic neuronal damage of prolonged focal cerebral ischemia and recirculation in rats Neurol Res 19 1997 192 203
31. H. Matsuno, T. Uematsu, K. Umemura, Y. Takiguchi, Y. Asai, Y. Muranaka, and M. Nakashima A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model J Pharmacol Toxicol Meth 29 1993 165 173
32. H. Matsuno, T. Uematsu, K. Umemura, Y. Takiguchi, K. Wada, and M. Nakashima Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator Br J Pharmacol 106 1992 533 538
33. W. Meng, X. Wang, M. Asahi, T. Kano, K. Asahi, R.H. Ackerman, and E.H. Lo Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats J Cereb Blood Flow Metab 19 1999 1316 1321
34. E. Mori, G.J. del Zoppo, J.D. Chambers, B.R. Copeland, and K.E. Arfors Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons Stroke 23 1992 712 718
35. A. Moriguchi, K. Mihara, T. Aoki, M. Maeda, N. Tojo, N. Matsuoka, and S. Mutoh Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig Eur J Pharmacol 498 2004 179 188
36. N. Nagai, B.Q. Zhao, Y. Suzuki, H. Ihara, T. Urano, and K. Umemura Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice J Cereb Blood Flow Metab 22 2002 648 651
37. Y. Okada, B.R. Copeland, R. Fitridge, J.A. Koziol, and G.J. del Zoppo Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion Stroke 25 1994 1847 1853 discussion 1853-4
38. Y. Okada, B.R. Copeland, E. Mori, M.M. Tung, W.S. Thomas, and G.J. del Zoppo P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion Stroke 25 1994 202 211
39. K. Overgaard, T. Sereghy, H. Pedersen, and G. Boysen Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model Neuroreport 3 1992 925 928
40. S.H. Rezkalla, and R.A. Kloner No-reflow phenomenon Circulation 105 2002 656 662
41. G.D. Rosen, and J.D. Harry Brain volume estimation from serial section measurements: a comparison of methodologies J Neurosci Meth 35 1990 115 124
42. S.I. Savitz, G. Gupta, M. Singh, and D.M. Rosenbaum Antithrombotic and thrombolytic therapy for ischemic stroke Clin Geriatr Med 17 2001 149 161
43. C. Seydoux, J.J. Goy, and G. Davies Platelet and neutrophil imaging techniques in the investigation of the response to thrombolytic therapy and the no-reflow phenomenon Am Heart J 125 1993 1142 1147
44. STAIR Recommendations for standards regarding preclinical neuroprotective and restorative drug development Stroke 30 1999 2752 2758
45. Y. Suzuki, Y. Takagi, K. Kawano, and K. Umemura A novel guinea pig model with cyclic flow reductions following thrombotic cerebral ischemia Brain Res Brain Res Protoc 10 2002 55 59
46. H. Takamatsu, H. Tsukada, T. Kakiuchi, S. Nishiyama, A. Noda, and K. Umemura Detection of reperfusion injury using PET in a monkey model of cerebral ischemia J Nucl Med 41 2000 1409 1416
47. A. Tamura, T. Asano, K. Sano, T. Tsumagari, and A. Nakajima Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital. A comparative study in chronic middle cerebral artery occlusion in cats Stroke 10 1979 126 134
48. A. Tamura, D.I. Graham, J. McCulloch, and G.M. Teasdale Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion J Cereb Blood Flow Metab 1 1981 53 60
49. E.J. Topol, and J.S. Yadav Recognition of the importance of embolization in atherosclerotic vascular disease Circulation 101 2000 570 580
50. E. Uhl, J. Beck, W. Stummer, J. Lehmberg, and A. Baethmann Leukocyte-endothelium interactions in pial venules during the early and late reperfusion period after global cerebral ischemia in gerbils J Cereb Blood Flow Metab 20 2000 979 987
51. K. Umemura, K. Wada, T. Uematsu, and M. Nakashima Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model Stroke 24 1993 1077 1081 discussion 1081-2
52. D. Virley, S.J. Hadingham, J.C. Roberts, B. Farnfield, H. Elliott, G. Whelan, J. Golder, C. David, A.A. Parsons, and A.J. Hunter A new primate model of focal stroke: endothelin-1-induced middle cerebral artery occlusion and reperfusion in the common marmoset J Cereb Blood Flow Metab 24 2004 24 41
53. M. Watanabe, H. Okada, K. Shimizu, T. Omura, E. Yoshikawa, T. Kosugi, S. Mori, and T. Yamashita A high resolution animal PET scanner using compact PS-PMT detectors IEEE Trans Nucl Sci 44 1997 1277 1282
54. B.D. Watson, W.D. Dietrich, R. Busto, M.S. Wachtel, and M.D. Ginsberg Induction of reproducible brain infarction by photochemically initiated thrombosis Ann Neurol 17 1985 497 504
55. L.R. Wechsler, R. Roberts, A.J. Furlan, R.T. Higashida, W. Dillon, H. Roberts, H.A. Rowley, L.C. Pettigrew, A.S. Callahan III, A. Bruno, P. Fayad, W.S. Smith, C.M. Firszt, and G.A. Schulz Factors influencing outcome and treatment effect in PROACT II Stroke 34 2003 1224 1229. Epub 2003 Apr 03.
56. K.S. Wong, H. Li, W.W. Lam, Y.L. Chan, and R. Kay Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke Stroke 33 2002 532 536
57. H. Yanamoto, I. Nagata, Y. Niitsu, J.H. Xue, Z. Zhang, and H. Kikuchi Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique Exp Neurol 182 2003 261 274
58. A.R. Young, O. Touzani, J.M. Derlon, G. Sette, E.T. MacKenzie, and J.C. Baron Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume Stroke 28 1997 632 637 discussion 637-8
59. Z.G. Zhang, L. Zhang, W. Tsang, A. Goussev, C. Powers, K.L. Ho, D. Morris, S.S. Smyth, B.S. Coller, and M. Chopp Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 912 2001 181 194
60. B.Q. Zhao, Y. Suzuki, K. Kondo, K. Kawano, Y. Ikeda, and K. Umemura A novel MCA occlusion model of photothrombotic ischemia with cyclic flow reductions: development of cerebral hemorrhage induced by heparin. Brain Res Brain Res Protoc 9 2002 85 92